2026
-$0.25
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$15,675K; dWC removed=$20,990K (operating asset/liability changes -2,058 incl. receivables +4,377 and real estate under development -6,203; build-to-suit property carrying value liquidated +12,823 = proceeds 14,317 less gain 1,494, gain kept in earnings; consolidated-fund sales 9,626 less purchases 3,339 = +6,287; consolidated-fund working capital +3,938); CFO-dWC=$(5,315)K; SBC=$2,284K; no capex disclosed, maintenance capex $0; OE=$(7,599)K; shares=30,289K (basic=diluted, loss year); OE/sh=$(0.2509). No GECC incentive fees (waived). Reconciliation: NI $(36,908)K + D&A 1,299 + SBC 2,284 + unrealized loss 27,344 - realized gain 5,100 + non-cash interest 2,152 - deferred tax 64 + other 1,080 + fund loss 2,659 - accretion 61 = $(5,315)K, matches. Source: FY2026 10-K, accession 0001193125-26-368246.
2025
$0.01
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$(9,006)K; dWC removed=$(11,235)K (operating asset/liability changes -10,165 incl. receivables -6,072 and real estate under development -3,406; real estate sale pair -109; consolidated-fund purchases -4,680 and principal +5,234 = +554; consolidated-fund working capital -1,515); CFO-dWC=$2,229K; SBC=$1,952K; no capex disclosed, maintenance capex $0; OE=$277K; diluted shares=38,817K; OE/sh=$0.0071. Includes $4,069K GECC incentive fees. Reconciliation: NI $15,550K + D&A 1,249 + SBC 1,952 + non-cash interest 2,204 + deferred tax 216 + other 1,326 - unrealized gain 15,991 - realized gain 396 - convertible gain 467 - fund gains/accretion 3,414 = $2,229K, matches. Source: FY2026 10-K, accession 0001193125-26-368246.
2024
-$0.02
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$(15,555)K; dWC removed=$(17,292)K (operating asset/liability changes -8,771 incl. real estate under development -8,329; build-to-suit property carrying value liquidated +5,102 = proceeds 6,163 less gain 1,061, gain kept in earnings; consolidated-fund purchases -12,040 and principal repayments +879 = -11,161; consolidated-fund working capital -2,462); CFO-dWC=$1,737K; SBC=$2,364K; no capex disclosed, maintenance capex $0; OE=$(627)K; diluted shares=29,962K; OE/sh=$(0.0209). Reconciliation: NI $(942)K + D&A 1,108 + SBC 2,364 + non-cash interest 2,373 - convertible note gain 2,252 - contingent 498 - other 246 - unrealized 39 + realized 79 - fund gains/accretion 210 = $1,737K, matches. Source: FY2025 10-K, accession 0001193125-25-194119.
2023
-$0.23
▼
OE = CFO - dWC - SBC - maintenance capex, continuing operations. CFO (continuing)=$(3,139)K; dWC removed=$818K (receivables -1,159, prepaid +1,012, real estate under development -1,682, leases -77, AP/accrued +1,166 = -740; consolidated-fund investment sales +1,558); CFO-dWC=$(3,957)K; SBC=$2,615K; capex=$53K, capex ratio mean 0.34% x revenue growth $4,147K = growth capex $14K, maintenance capex $39K; OE=$(6,611)K; shares=28,910K basic (diluted count antidilutive for negative OE); OE/sh=$(0.2287). Reconciliation: NI cont. $14,479K + D&A 1,152 + SBC 2,615 + non-cash interest 2,299 + contingent consideration 783 + other 470 + fund loss 16 - unrealized gain 10,948 - realized gain 4,299 - gain on sale of controlling interest 10,524 = $(3,957)K, matches. Source: FY2023 10-K, accession 0000950170-23-049001.
2022
-$0.34
▼
OE = CFO - dWC - SBC - maintenance capex, continuing operations (durable medical equipment business later reclassified as discontinued). CFO (continuing)=$17,061K; dWC removed=$23,246K (operating asset/liability changes +$72K; consolidated-fund investment sales $41,692K less purchases $18,518K = +$23,174K, treated as fund working capital, not earnings); CFO-dWC=$(6,185)K; SBC=$2,802K; capex=$3K, all treated as maintenance (prior-year continuing revenue not available); OE=$(8,990)K; shares=26,784K (basic=diluted, loss year); OE/sh=$(0.3357). Reconciliation: NI $(19,305)K + D&A 524 + SBC 2,802 + non-cash interest 2,048 + realized loss 8,194 - unrealized gain 623 + fund realized/unrealized 525 - stock dividends 350 = $(6,185)K, matches. Investment gains/losses excluded by construction. Source: FY2023 10-K (restated FY2022 continuing ops), accession 0000950170-23-049001.
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.